rs60637

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_014191.4(SCN8A):​c.5472C>A​(p.Pro1824=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.698 in 1,613,622 control chromosomes in the GnomAD database, including 406,832 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.60 ( 30605 hom., cov: 32)
Exomes 𝑓: 0.71 ( 376227 hom. )

Consequence

SCN8A
NM_014191.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:17

Conservation

PhyloP100: -0.0570
Variant links:
Genes affected
SCN8A (HGNC:10596): (sodium voltage-gated channel alpha subunit 8) This gene encodes a member of the sodium channel alpha subunit gene family. The encoded protein forms the ion pore region of the voltage-gated sodium channel. This protein is essential for the rapid membrane depolarization that occurs during the formation of the action potential in excitable neurons. Mutations in this gene are associated with cognitive disability, pancerebellar atrophy and ataxia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 12-51806958-C-A is Benign according to our data. Variant chr12-51806958-C-A is described in ClinVar as [Benign]. Clinvar id is 130251.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-51806958-C-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.057 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.75 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SCN8ANM_001330260.2 linkuse as main transcriptc.5472C>A p.Pro1824= synonymous_variant 27/27 ENST00000627620.5 NP_001317189.1
SCN8ANM_014191.4 linkuse as main transcriptc.5472C>A p.Pro1824= synonymous_variant 27/27 ENST00000354534.11 NP_055006.1
SCN8ANM_001177984.3 linkuse as main transcriptc.5349C>A p.Pro1783= synonymous_variant 26/26 NP_001171455.1
SCN8ANM_001369788.1 linkuse as main transcriptc.5349C>A p.Pro1783= synonymous_variant 26/26 NP_001356717.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SCN8AENST00000354534.11 linkuse as main transcriptc.5472C>A p.Pro1824= synonymous_variant 27/271 NM_014191.4 ENSP00000346534 P4Q9UQD0-1
SCN8AENST00000627620.5 linkuse as main transcriptc.5472C>A p.Pro1824= synonymous_variant 27/275 NM_001330260.2 ENSP00000487583 A1Q9UQD0-2

Frequencies

GnomAD3 genomes
AF:
0.603
AC:
91608
AN:
151874
Hom.:
30597
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.308
Gnomad AMI
AF:
0.816
Gnomad AMR
AF:
0.707
Gnomad ASJ
AF:
0.657
Gnomad EAS
AF:
0.573
Gnomad SAS
AF:
0.365
Gnomad FIN
AF:
0.705
Gnomad MID
AF:
0.601
Gnomad NFE
AF:
0.756
Gnomad OTH
AF:
0.654
GnomAD3 exomes
AF:
0.654
AC:
163303
AN:
249530
Hom.:
56723
AF XY:
0.647
AC XY:
87547
AN XY:
135340
show subpopulations
Gnomad AFR exome
AF:
0.295
Gnomad AMR exome
AF:
0.746
Gnomad ASJ exome
AF:
0.678
Gnomad EAS exome
AF:
0.574
Gnomad SAS exome
AF:
0.363
Gnomad FIN exome
AF:
0.720
Gnomad NFE exome
AF:
0.751
Gnomad OTH exome
AF:
0.686
GnomAD4 exome
AF:
0.707
AC:
1033975
AN:
1461630
Hom.:
376227
Cov.:
64
AF XY:
0.699
AC XY:
507872
AN XY:
727082
show subpopulations
Gnomad4 AFR exome
AF:
0.291
Gnomad4 AMR exome
AF:
0.743
Gnomad4 ASJ exome
AF:
0.678
Gnomad4 EAS exome
AF:
0.529
Gnomad4 SAS exome
AF:
0.370
Gnomad4 FIN exome
AF:
0.733
Gnomad4 NFE exome
AF:
0.752
Gnomad4 OTH exome
AF:
0.685
GnomAD4 genome
AF:
0.603
AC:
91631
AN:
151992
Hom.:
30605
Cov.:
32
AF XY:
0.598
AC XY:
44391
AN XY:
74270
show subpopulations
Gnomad4 AFR
AF:
0.308
Gnomad4 AMR
AF:
0.707
Gnomad4 ASJ
AF:
0.657
Gnomad4 EAS
AF:
0.572
Gnomad4 SAS
AF:
0.367
Gnomad4 FIN
AF:
0.705
Gnomad4 NFE
AF:
0.756
Gnomad4 OTH
AF:
0.649
Alfa
AF:
0.706
Hom.:
48984
Bravo
AF:
0.598
Asia WGS
AF:
0.439
AC:
1526
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:17
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jan 12, 2016- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJul 15, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 88% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 82. Only high quality variants are reported. -
not provided Benign:3
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMay 07, 2018- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 31, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Early infantile epileptic encephalopathy with suppression bursts Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Cognitive impairment with or without cerebellar ataxia Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 15, 2021- -
Seizures, benign familial infantile, 5 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 15, 2021- -
Myoclonus, familial, 2 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 15, 2021- -
Developmental and epileptic encephalopathy, 13 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 15, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.40
CADD
Benign
6.4
DANN
Benign
0.85

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs60637; hg19: chr12-52200742; COSMIC: COSV61977088; COSMIC: COSV61977088; API